Capital International Investors
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1562230
Los Angeles, CA
Position in VRTX
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$2,288,998,423
+$142,975,341 QoQ
Shares Held
5,126,077
+8.3% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.57%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
15 quarters on record
Voting authority
Sole 99.94869370865868.ToString("F0")%
Shared 0.ToString("F0")%
None 0.05130629134131227.ToString("F0")%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Capital International Investors holds $7,233,634,148 across 15 Biotechnology names. VRTX ranks #1 (31.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
5,126,077 | $2,288,998,423 | |
| 2 | RPRX |
Royalty Pharma plc
|
35,005,736 | $1,679,225,155 | |
| 3 | ONC |
BeOne Medicines Ltd.
|
4,158,726 | $1,235,016,860 | |
| 4 | INSM |
INSMED Inc
|
5,595,194 | $914,926,122 | |
| 5 | ASND |
Ascendis Pharma A/S
|
1,958,843 | $448,046,159 | |
| 6 | XENE |
Xenon Pharmaceuticals Inc.
|
2,674,727 | $155,535,375 | |
| 7 | RAPP |
Rapport Therapeutics, Inc.
|
3,097,973 | $96,935,575 | |
| 8 | CYTK |
Cytokinetics Inc
|
1,338,803 | $88,240,505 |
All Filings in VRTX
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,288,998,423 | 5,126,077 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $2,146,023,082 | 4,733,596 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $1,836,423,066 | 4,689,059 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $1,173,504,015 | 2,635,903 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $315,084,033 | 649,899 | Shares | Defined | 2025-05-12 | |
| 2024-12-31 | $137,929,582 | 342,512 | Shares | Defined | 2025-02-13 | |
| 2022-03-31 | $32,776,527 | 125,595 | Shares | Defined | 2022-05-19 | |
| 2021-12-31 | $445,180,147 | 2,027,232 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $716,409,237 | 3,949,552 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $917,215,474 | 4,549,003 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $1,298,487,652 | 6,042,569 | Shares | Defined | 2021-05-14 | |
| 2020-12-31 | $1,580,032,635 | 6,685,422 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $1,492,873,178 | 5,486,084 | Shares | Defined | 2020-11-13 | |
| 2020-06-30 | $1,668,559,337 | 5,747,509 | Shares | Defined | 2020-08-14 | |
| 2020-03-31 | $1,556,811,194 | 6,542,598 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||